1081O ctDNA reduction and clinical efficacy of the darovasertib + crizotinib (daro + crizo) combination in metastatic uveal melanoma (MUM)

Autor: Mckean, M., Chmielowski, B., Butler, M.O., Carvajal, R., Rodon, J., Carlino, M., Kim, K.B., Wise-draper, T., Khan, S., Salama, A.K.S., Moser, J., Reeves, J., Wilner, K.D., Maurer, M., Abed, M., Mitchell, B., Beaupre, D., Orloff, M.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S651-S651
Databáze: ScienceDirect